Primary Device ID | 03573026403997 |
NIH Device Record Key | 01c26d7a-4b02-44de-83b7-7e0c07c9bdb9 |
Commercial Distribution Discontinuation | 2018-12-31 |
Commercial Distribution Status | Not in Commercial Distribution |
Brand Name | ARGENE® ADENOVIRUS R-gene KIT US |
Version Model Number | 69-010B-US |
Company DUNS | 276816717 |
Company Name | BIOMERIEUX SA |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | true |
Device Combination Product | false |
Single Use | false |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Storage Environment Temperature | Between -31 Degrees Celsius and -15 Degrees Celsius |
Device Issuing Agency | Device ID |
---|---|
GS1 | 03573026403997 [Primary] |
OCC | Respiratory Virus Panel Nucleic Acid Assay System |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 4 |
Public Version Date | 2020-01-23 |
Device Publish Date | 2016-10-17 |
03573026256685 - ETEST® Gentamicin (GM) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026376604 - ETEST® Amoxicillin (AC) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026377731 - ETEST® Flucytosine (FC) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions |
03573026560690 - ETEST® Meropenem/Vaborbactam (MEV) | 2024-04-15 ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative an |
03573026475352 - ETEST® Telavancin (TLA) | 2024-04-12 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026252526 - ETEST® Cefepime (PM) | 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026253219 - Etest® TIC/CLAV-CON2 | 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026617851 - VITEK®MS | 2024-03-18 VITEK MS ready to use reagent for calibration and fine tuning of the VITEK MS instrument |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ARGENE 86890878 5225927 Live/Registered |
bioMérieux 2016-01-29 |
ARGENE 79041692 3527706 Live/Registered |
bioMérieux 2007-07-06 |
ARGENE 72209559 0815126 Dead/Expired |
VIENNA BEAUTY PRODUCTS COMPANY 1965-01-07 |